1. Home
  2. PRTA vs SWBI Comparison

PRTA vs SWBI Comparison

Compare PRTA & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$9.78

Market Cap

482.3M

Sector

Health Care

ML Signal

N/A

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

N/A

Current Price

$14.30

Market Cap

491.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PRTA
SWBI
Founded
2012
1852
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
482.3M
491.2M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
PRTA
SWBI
Price
$9.78
$14.30
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$19.00
$14.00
AVG Volume (30 Days)
383.0K
463.5K
Earning Date
01-01-0001
06-04-2026
Dividend Yield
N/A
3.72%
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$814,000.00
$474,661,000.00
Revenue This Year
$1,111.38
$2.62
Revenue Next Year
N/A
$3.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.32
$7.73
52 Week High
$14.60
$13.96

Technical Indicators

Market Signals
Indicator
PRTA
SWBI
Relative Strength Index (RSI) 58.44 80.86
Support Level $9.54 $7.91
Resistance Level $10.72 N/A
Average True Range (ATR) 0.57 0.39
MACD 0.12 0.23
Stochastic Oscillator 80.45 93.44

Price Performance

Historical Comparison
PRTA
SWBI

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: